John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP

  • Predictors of severity of hypertensive response in acute intracerebral haemorrhage

    Date published:

  • The Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT): progress and challenges

    Date published:

  • Polygenic risk score can replace clinical risk scores in predicting diabetic complications and their response to therapy

    Date published:

  • Is blood pressure lowering for secondary stroke prevention in the very elderly associated with a higher risk of adverse events?

    Date published:

  • Comparison between right and left acute ischaemic stroke patients treated with intravenous alteplase in the ENCHANTED trial

    Date published:

  • Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk

    Health Policy Date published:

  • N-Glycan Profile and Kidney Disease in Type 1 Diabetes

    Diabetes Care Date published:

  • Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke

    JAMA Neurology Date published:

  • Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON

    Diabetes Care Date published:

  • Positive impact of the participation in the ENCHANTED trial in reducing Door-to-Needle Time

    Scientific Reports Date published:

  • MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: a randomised controlled trial protocol

    BMJ Open Date published:

  • Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data

    The Lancet Diabetes & Endocrinology Date published:

  • [OP.4A.11] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION

    Journal of Hypertension Date published:

  • Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke

    Stroke Date published:

  • Plasma lipidomic profiles in two large independent cohorts improve upon conventional risk factors to predict cardiovascular events

    Atherosclerosis Date published:

  • Microvascular outcomes in type 2 diabetes - Authors' reply

    The Lancet Diabetes & Endocrinology Date published: